Eleven variants identified only one additional breast-cancer-affected carrier in the pedigrees in which they were identified (CHD5, DYSF, GZMA, AKAP11, MED14, EPHX1, SOX13, ACSS2, ACTL7A variant 1, SLCO1B3, and FBN1). This evidence concerns the gene CHD5 and breast cancer.